1. Home
  2. GLBS vs RLMD Comparison

GLBS vs RLMD Comparison

Compare GLBS & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLBS
  • RLMD
  • Stock Information
  • Founded
  • GLBS 2006
  • RLMD 2004
  • Country
  • GLBS Greece
  • RLMD United States
  • Employees
  • GLBS N/A
  • RLMD N/A
  • Industry
  • GLBS Marine Transportation
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLBS Consumer Discretionary
  • RLMD Health Care
  • Exchange
  • GLBS Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • GLBS 21.2M
  • RLMD 20.3M
  • IPO Year
  • GLBS 2007
  • RLMD N/A
  • Fundamental
  • Price
  • GLBS $1.01
  • RLMD $0.63
  • Analyst Decision
  • GLBS Strong Buy
  • RLMD Buy
  • Analyst Count
  • GLBS 1
  • RLMD 3
  • Target Price
  • GLBS $3.00
  • RLMD $5.00
  • AVG Volume (30 Days)
  • GLBS 35.8K
  • RLMD 142.9K
  • Earning Date
  • GLBS 09-11-2025
  • RLMD 08-07-2025
  • Dividend Yield
  • GLBS N/A
  • RLMD N/A
  • EPS Growth
  • GLBS N/A
  • RLMD N/A
  • EPS
  • GLBS N/A
  • RLMD N/A
  • Revenue
  • GLBS $35,776,000.00
  • RLMD N/A
  • Revenue This Year
  • GLBS $5.01
  • RLMD N/A
  • Revenue Next Year
  • GLBS $27.86
  • RLMD N/A
  • P/E Ratio
  • GLBS N/A
  • RLMD N/A
  • Revenue Growth
  • GLBS 17.92
  • RLMD N/A
  • 52 Week Low
  • GLBS $0.99
  • RLMD $0.24
  • 52 Week High
  • GLBS $2.21
  • RLMD $3.98
  • Technical
  • Relative Strength Index (RSI)
  • GLBS 41.54
  • RLMD 51.70
  • Support Level
  • GLBS $1.00
  • RLMD $0.59
  • Resistance Level
  • GLBS $1.11
  • RLMD $0.64
  • Average True Range (ATR)
  • GLBS 0.04
  • RLMD 0.05
  • MACD
  • GLBS 0.00
  • RLMD 0.00
  • Stochastic Oscillator
  • GLBS 12.73
  • RLMD 55.00

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: